Efficacy of a rapid response team on reducing the incidence and mortality of unexpected cardiac arrests

Trauma Monthly
Majid SabahiFarokh Sadat Falsafi

Abstract

Rapid Response Teams (RRTs) assess patients during early phases of deterioration to reduce patient morbidity and mortality. This study aimed to evaluate the ability of earlier medical intervention by a RRT prompted by clinical instability in patients to reduce the incidence of and mortality from unexpected cardiac arrest at our hospital. A nonrandomized, population-based study before 2008 and after 2010 introduction of the Rapid Response Teams in a 300 bed private hospital. All patients were admitted to the hospital in 2008 (n = 25348) and 2010 (n = 28024). RRT (One doctor, one senior intensive care nurse and one staff nurse) attended to clinically unstable patients immediately with resuscitation drugs, fluid, and equipment. Response was activated by the bedside nurse or doctor according to predefined criteria. Main outcome measures were incidence and outcome of unexpected cardiac arrest. The incidence of unexpected cardiac arrest was 17 per 1000 hospital admissions (431 cases) in 2008 (before RRT intervention) and 12.45 per 1000 admissions (349 cases) in 2010 (after intervention), with mortality being 73.23% (274 patients) and 66.15% (231 patients) respectively. After adjustment for case mix the intervention was associated wit...Continue Reading

References

Jun 11, 1977·Lancet·R C PeatfieldM W McNicol
Dec 1, 1990·Chest·R M ScheinC L Sprung
Sep 8, 1983·The New England Journal of Medicine·S E BedellF H Epstein
Feb 1, 1995·Resuscitation·T J HodgettsJ Hanson
Apr 1, 1995·Anaesthesia and Intensive Care·A LeeK Daffurn
May 26, 1999·The Medical Journal of Australia·R M WilsonJ D Hamilton
Mar 7, 2001·BMJ : British Medical Journal·C VincentM Woloshynowych
Sep 1, 2001·Internal Medicine Journal·K M HillmanG Simmons
Nov 5, 2002·Intensive Care Medicine·Ken M HillmanGrant Simmons
Sep 11, 2003·The Medical Journal of Australia·Rinaldo BellomoGeoffrey Gutteridge
Jun 3, 2004·Resuscitation·Gary KenwardLoua Shaikh
Jun 21, 2005·Lancet·Ken HillmanUNKNOWN MERIT study investigators
Dec 17, 2005·Critical Care : the Official Journal of the Critical Care Forum·Daryl JonesGeoffrey Gutteridge
Jan 30, 2007·Critical Care : the Official Journal of the Critical Care Forum·Daryl JonesDonna Goldsmith
Mar 21, 2007·Resuscitation·Daryl JonesRinaldo Bellomo
May 15, 2007·The Journal of Trauma·Patrick J OffnerRobin Roberts
Sep 15, 2007·Critical Care Medicine·Michael J DaceyRobert Baute
Sep 18, 2007·Journal of Nursing Care Quality·Susan J McFarlan, Sara Hensley
Apr 9, 2008·Critical Care : the Official Journal of the Critical Care Forum·Daryl JonesJacqueline Martin
Dec 4, 2008·JAMA : the Journal of the American Medical Association·Paul S ChanJohn A Spertus
Oct 15, 2009·Critical Care : the Official Journal of the Critical Care Forum·Daryl JonesMichael A DeVita
Jan 13, 2010·Archives of Internal Medicine·Paul S ChanComilla Sasson
Jul 15, 2011·The New England Journal of Medicine·Daryl A JonesRinaldo Bellomo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.